heart failure
Conditions
Interventions
Experimental group:MC-780MA body composition analyzer to evaluate the treatment plan of heart failure patients under the change of volume load
Sponsors
Zhongda Hospital of Southeast University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with heart failure in accordance with the ''Chinese Heart Failure Diagnosis and Treatment Guidelines 2018'' according to the basic heart disease history, systemic circulation congestion, pulmonary circulation congestion symptoms, signs and related examinations; 2. According to the New York Heart Association (NYHA) cardiac function classification, patients with cardiac function III to IV have symptoms and signs of heart failure; 3. Structural heart disease (left ventricular hypertrophy, left atrial enlargement) and (or) diastolic dysfunction; 4. Elevated plasma ventricular natriuretic peptide (BNP) or NT-proBNP levels.
Exclusion criteria
Exclusion criteria: 1. Patients with congenital heart disease; 2. Patients with acute myocardial infarction; 3. Patients with severe arrhythmia; 4. Patients with aortic dissection and aortic aneurysm; 5. Patients with malignant tumor; 6. Severe liver and kidney dysfunction; 7. Severe lung disease; 8. Severe anemia; 9. Severe thyroid dysfunction; 10. Patients with irregular medication and poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NYHA classification of cardiac function;death from cardiovascular causes;rehospitalization for heart failure; | — |
Secondary
| Measure | Time frame |
|---|---|
| 6-minute walk distance;cardiac ultrasound (automatic functional imaging);Minnesota cardiac impairment quality of life scale;plasma N-terminal pro-brain natriuretic peptide concentration; | — |
Countries
China
Contacts
Public ContactYan Gaoliang
Zhongda Hospital of Southeast University
Outcome results
None listed